Abiopharma

🔍 Fisher Adam Ralph (Executive)

Company: Fiverr International Ltd. (FVRR)

Report Date: 2026-06-08

Detailed Transactions and Holdings:

• Sold 0 shares of Ordinary Shares (Direct)
  Date: 2026-06-08 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 0 shares of Ordinary Shares (Direct)
  Date: 2026-06-09 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F2, F2
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-06-08 | Code: H | shares_owned_after: 65,704.00

Footnotes:

• F1: On June 8, 2026, Bessemer Venture Partners VII Institutional L.P. ("BVP VII Inst"), Bessemer Venture Partners VII L.P. ("BVP VII"), and BVP VII Special Opportunity Fund L.P. ("BVP VII SOF") (together with BVP VII Inst and BVP VIII, the "Bessemer Funds") sold 9,086, 20,767 and 35,045 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $10.34. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.47. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F2: On June 9, 2026, BVP VII Inst, BVP VII and BVP VII SOF sold 13,204, 30,179 and 50,930 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $10.36. These shares were sold in multiple transactions at prices ranging from $10.12 to $10.52. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F3: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer VII & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.